| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Monday’s Close |
|---|---|---|---|---|---|
| ABBV | AbbVie Inc. | $95.37 | $144.42B | N/A |
The Zacks Analyst Blog Highlights: Microsoft, Home Depot, AbbVie, Disney and Host Hotels
http://www.zacks.com/stock/news/509524/the-zacks-analyst-blog-highlights-microsoft-home-depot-abbvie-disney-and-host-hotels?cid=CS-ZC-FT-press_releases-509524
Sep 09, 2019 - The Zacks Analyst Blog Highlights: Microsoft, Home Depot, AbbVie, Disney and Host Hotels
0
Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio
http://www.zacks.com/stock/news/512942/why-abbvie-abbv-is-a-top-dividend-stock-for-your-portfolio?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-512942
Sep 11, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
0
4 Big Drugmakers Boasting Impressive Oncology Pipelines
http://www.zacks.com/stock/news/513001/4-big-drugmakers-boasting-impressive-oncology-pipelines?cid=CS-ZC-FT-analyst_blog|industry_focus-513001
Sep 11, 2019 - We discuss four pharma giants, which possess the industry's strongest oncology pipeline portfolios.
0
Anxious About AbbVie? Here Are 4 Things You Should Know
https://www.fool.com/investing/2019/09/12/anxious-about-abbvie-here-are-4-things-you-should.aspx?source=iedfolrf0000001
Sep 12, 2019 - The situation for AbbVie probably isn't nearly as bad as you think it is.
0
Dividend Growth ETFs for Long Term Investors
http://www.zacks.com/stock/news/517301/dividend-growth-etfs-for-long-term-investors?cid=CS-ZC-FT-etf_news_and_commentary-517301
Sep 13, 2019 - Dividend growth ETFs hold companies with solid balance sheets and rising earnings.
0
Here is Why Growth Investors Should Buy AbbVie (ABBV) Now
http://www.zacks.com/stock/news/542551/here-is-why-growth-investors-should-buy-abbvie-abbv-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_11_growth-542551
Sep 30, 2019 - AbbVie (ABBV) could produce exceptional returns because of its solid growth attributes.
0
AbbVie (ABBV) Gets FDA Nod for Label Expansion of HCV Drug
http://www.zacks.com/stock/news/539107/abbvie-abbv-gets-fda-nod-for-label-expansion-of-hcv-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-539107
Sep 27, 2019 - AbbVie (ABBV) gets FDA approval for the label expansion of Mavyret.
0
Top Stock Reports for AbbVie, Starbucks & Phillips 66
http://www.zacks.com/research-daily/544529/top-stock-reports-for-abbvie-starbucks-phillips-66?cid=CS-ZC-FT-research_daily-544529
Oct 01, 2019 - Top Stock Reports for AbbVie, Starbucks & Phillips 66
0
Top Ranked Income Stocks to Buy for October 2nd
http://www.zacks.com/commentary/545738/top-ranked-income-stocks-to-buy-for-october-2nd?cid=CS-ZC-FT-zacks_#1_rank_additions-545738
Oct 02, 2019 - Top Ranked Income Stocks to Buy for October 2nd
0
3 Top Dividend Stocks to Buy Right Now
https://www.fool.com/investing/2019/10/06/3-top-dividend-stocks-to-buy-right-now.aspx?source=iedfolrf0000001
Oct 06, 2019 - With high yields and solid growth prospects, these companies deserve income investors' attention.
0
Page 1>